LARA COMPTON
Member
Mintz
Mintz member Lara Compton is a trusted advisor to clients ranging from traditional health care providers to disrupter digital health platforms as they navigate the practical and regulatory challenges in health care. Her unique depth of knowledge across HIPAA privacy and other regulatory issues governing the use of data, state and federal fraud and abuse laws, business planning and operational issues has led colleagues to describe Lara as the “Swiss Army knife” of health care problem-solving.
As a successful health care attorney, Compton has recently worked on some noteworthy matters including serving as the lead health care regulatory counsel to Fulgent Genetics, Inc., a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, in its $170 million acquisition of Inform Diagnostics and a portfolio company of Avista Capital Partners. Compton led the healthcare regulatory due diligence team for the deal.
